Michael Brundage, MSc, FRCPC, MD (Interim Director, QCRI) has appointed Christopher Booth, MD, FRCPC as Director, CCE Division, QCRI.
Dr. Booth is a Medical Oncologist and Health Services Researcher. He is a Professor of Oncology and Public Health Sciences and holds the Canada Research Chair in Population Cancer Care.
Dr. Booth studied medicine at Queen’s University. He did postgraduate training in Internal Medicine and Medical Oncology at the University of Toronto followed by a research fellowship with the NCIC Clinical Trials Group. In his clinical practice he provides care to patients with gastrointestinal cancers. Dr. Booth’s research program explores access, quality, and value of cancer care in Canada and globally.
In 2016 Dr. Booth spent a sabbatical as a visiting scientist at the Regional Cancer Centre in Trivandrum, India. He is an Advisor (Health Services Research) to the National Cancer Grid of India, an Honorary Consultant at Pallium India, and a member of the WHO Essential Medicine List Cancer Working Group.
Dr. Booth has published over 250 peer-reviewed manuscripts and has served as research supervisor for >25 trainees.
Please join Dr. Brundage in congratulating Dr. Booth on his appointment as Director, CCE Division, Queen’s Cancer Research Institute.